BridgeBio Pharma Launches CoA Therapeutics To Target Coenzyme-A For Rare Genetic Disorders

Wednesday, June 13, 2018 1 min read

Key Takeaway: BridgeBio Pharma Launches CoA Therapeutics To Target Coenzyme-A For Rare Genetic Disorders

Full Press Release Details

BridgeBio Pharma Launches CoA Therapeutics To Target Coenzyme-A For Rare Genetic Disorders.